Human induced pluripotent stem cells are found to be nearly identical to embryonic stem cells, supporting their suitability for clinical applications.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Takahashi, K. et al. Cell 131, 861–872 (2007).
Choi, J. et al. Nat. Biotechnol. 33, 1173–1181 (2015).
Soares, F.A., Sheldon, M., Rao, M., Mummery, C. & Vallier, L. Stem Cell Rep. 3, 931–939 (2014).
Vallier, L. et al. Stem Cells 27, 2655–2666 (2009).
Bock, C. et al. Cell 144, 439–452 (2011).
Osafune, K. et al. Nat. Biotechnol. 26, 313–315 (2008).
Kim, K. et al. Nature 467, 285–290 (2010).
Rouhani, F. et al. PLoS Genet. 10, e1004432 (2014).
Kajiwara, M. et al. Proc. Natl. Acad. Sci. USA 109, 12538–12543 (2012).
Stadtfeld, M. et al. Nature 465, 175–181 (2010).
ENCODE Project Consortium. Nature 489, 57–74 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Vallier, L. Putting induced pluripotent stem cells to the test. Nat Biotechnol 33, 1145–1146 (2015). https://doi.org/10.1038/nbt.3401
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3401